Kiora Pharmaceuticals Inc（KPRX）资讯与事件

$1.410

-0.085 (-6.00%)收盘时

KPRX 资讯

Kiora Pharmaceuticals to Participate in Investor Fireside Chat

Kiora Pharmaceuticals Q1 Financial Analysis

KIORA PHARMACEUTICALS INC Reports Q1 Loss of $0.58 Per Share in SEC Filing

Kiora Pharmaceuticals Secures $24 Million Financing to Advance Eye Disease Treatments

KIORA PHARMACEUTICALS INC TO OFFER 438,471 COMMON STOCK SHARES THROUGH PRIVATE PLACEMENT - SEC FILING

Kiora Pharmaceuticals Reports FY 2025 Financial Results

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Kiora Pharmaceuticals gets approval to initiate mid-stage trial for eye disorder treatment

5/18 16:40

Kiora Pharmaceuticals Files to Sell 11.8M Shares of Common Stock

Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders

本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。